BRIEF published on 03/11/2024 at 13:05, 1 year 9 months ago Kayne Anderson Growth Capital Acquires Majority Stake in Telehealth Leader TeleMed2U Healthcare Technology Investment Kayne Anderson Growth Capital Telehealth TeleMed2U
BRIEF published on 03/11/2024 at 13:05, 1 year 9 months ago Kayne Anderson Growth Capital acquiert une participation majoritaire dans le leader de la télésanté TeleMed2U Investissement Technologie De La Santé Télésanté TeleMed2U Kayne Anderson Capital De Croissance
PRESS RELEASE published on 03/11/2024 at 13:00, 1 year 9 months ago Kayne Anderson Growth Capital Invests in TeleMed2U, a Multi-Specialty Telehealth Platform TeleMed2U announces strategic partnership with Kayne Anderson Growth Capital for enhanced telemedicine services and network expansion Healthcare Technology Strategic Partnership Kayne Anderson Growth Capital TeleMed2U Telemedicine Solutions
Published on 12/18/2025 at 00:55, 2 hours 59 minutes ago Molten Metals Corp. Announces Flow-Through Financing
Published on 12/18/2025 at 00:00, 3 hours 54 minutes ago Right Season Investments Announces Name Change to FutureGen Industries Corp.
Published on 12/17/2025 at 23:15, 4 hours 39 minutes ago Northern Superior Announces the Ratio for the Distribution of the Common Shares in the Capital of ONGold Resources Ltd.
Published on 12/17/2025 at 15:00, 12 hours 54 minutes ago BlackBerry Unveils Ground-Up Modernization of BlackBerry AtHoc Mobile Experience to Enable More Intelligent Operations
Published on 12/17/2025 at 14:00, 13 hours 54 minutes ago UniDoc Completes H3 Health Cube Installation in Italy
Published on 12/18/2025 at 01:10, 2 hours 44 minutes ago Samsung To Unveil New AI-Connected Living Lineup at CES 2026
Published on 12/18/2025 at 00:50, 3 hours 4 minutes ago Historic production of graphene enhanced cement successfully completed
Published on 12/17/2025 at 22:05, 5 hours 49 minutes ago Abivax annonce l’acceptation de 22 abstracts sur obefazimod dans les MICI à l’ECCO 2026, dont une présentation orale sur des résultats précliniques antifibrotiques
Published on 12/17/2025 at 22:05, 5 hours 49 minutes ago Abivax Announces Acceptance of 22 Abstracts Evaluating Obefazimod in Inflammatory Bowel Disease at ECCO 2026, Featuring an Oral Presentation on Preclinical Anti-Fibrotic Findings
Published on 12/17/2025 at 21:22, 6 hours 32 minutes ago EQS-Adhoc: DATAGROUP SE: DATAGROUP SE Management Board plans dividend of EUR 0.04 per share
Published on 12/17/2025 at 20:39, 7 hours 15 minutes ago Aeroports de Paris SA | 2026 Airport charges in Paris
Published on 12/17/2025 at 20:39, 7 hours 15 minutes ago Aeroports de Paris SA | Tarifs des redevances aeroportuaires 2026 à Paris
Published on 12/17/2025 at 19:30, 8 hours 24 minutes ago Evolution de la composition du Conseil d’Administration
Published on 12/17/2025 at 18:00, 9 hours 54 minutes ago Outstanding Shares and Voting Rights Statement at 30 November 2025
